会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering
    • 生物合成纤维素(BC)植入物和组织工程支架的三维生物印迹
    • US08691974B2
    • 2014-04-08
    • US13498657
    • 2010-09-28
    • Paul GatenholmHenrik BackdahlTheodore Jon TzavarasRafael V. DavalosMichael B. Sano
    • Paul GatenholmHenrik BackdahlTheodore Jon TzavarasRafael V. DavalosMichael B. Sano
    • C08B1/00A61K31/717C12P1/04C12N11/12
    • C08B1/00A61L27/20A61L27/38A61L27/56A61L2400/12C12N5/0062C12N11/12C12N2533/78C12P19/04C08L1/02
    • A novel BC fermentation technique for controlling 3D shape, thickness and architecture of the entangled cellulose nano-fibril network is presented. The resultant nano-cellulose based structures are useful as biomedical implants and devices, are useful for tissue engineering and regenerative medicine, and for health care products. More particularly, embodiments of the present invention relate to systems and methods for the production and control of 3-D architecture and morphology of nano-cellulose biomaterials produced by bacteria using any biofabrication process, including the novel 3-D Bioprinting processes disclosed. Representative processes according to the invention involve control of the rate of production of biomaterial by bacteria achieved by meticulous control of the addition of fermentation media using a microfluidic system. In exemplary embodiments, the bacteria gradually grew up along the printed alginate structure that had been placed into the culture, incorporating it. After culture, the printed alginate structure was successfully removed revealing porosity where the alginate had been placed. Porosity and interconnectivity of pores in the resultant 3-D architecture can be achieved by porogen introduction using, e.g., ink-jet printer technology.
    • 提出了一种用于控制缠结纤维素纳米纤维网络的3D形状,厚度和结构的新型BC发酵技术。 所得的纳米纤维素基结构可用作生物医学植入物和装置,可用于组织工程和再生医学以及保健产品。 更具体地说,本发明的实施方案涉及使用任何生物制造方法生产和控制由细菌生产的纳米纤维素生物材料的三维结构和形态的系统和方法,包括所公开的新型3-D生物印迹方法。 根据本发明的代表性方法涉及通过细微控制使用微流体系统添加发酵培养基来控制细菌生物材料的生产速率。 在示例性实施方案中,细菌沿已经放入培养物中的印刷的藻酸盐结构逐渐长大,并入其中。 培养后,成功去除了印刷的藻酸盐结构,显示了藻酸盐放置的孔隙度。 所得3-D结构中孔隙的孔隙率和互连性可以通过使用例如喷墨打印机技术的致孔剂引入来实现。
    • 2. 发明申请
    • THREE-DIMENSIONAL BIOPRINTING OF BIOSYNTHETIC CELLULOSE (BC) IMPLANTS AND SCAFFOLDS FOR TISSUE ENGINEERING
    • 生物塑料纤维素(BC)植物和组织的组织工程三维生物学
    • US20120190078A1
    • 2012-07-26
    • US13498657
    • 2010-09-28
    • Paul GatenholmHenrik BackdahlTheodore Jon TzavarasRafael V. DavalosMichael B. Sano
    • Paul GatenholmHenrik BackdahlTheodore Jon TzavarasRafael V. DavalosMichael B. Sano
    • C12P19/04C12N5/02C12N11/12
    • C08B1/00A61L27/20A61L27/38A61L27/56A61L2400/12C12N5/0062C12N11/12C12N2533/78C12P19/04C08L1/02
    • A novel BC fermentation technique for controlling 3D shape, thickness and architecture of the entangled cellulose nano-fibril network is presented. The resultant nano-cellulose based structures are useful as biomedical implants and devices, are useful for tissue engineering and regenerative medicine, and for health care products. More particularly, embodiments of the present invention relate to systems and methods for the production and control of 3-D architecture and morphology of nano-cellulose biomaterials produced by bacteria using any biofabrication process, including the novel 3-D Bioprinting processes disclosed. Representative processes according to the invention involve control of the rate of production of biomaterial by bacteria achieved by meticulous control of the addition of fermentation media using a microfluidic system. In exemplary embodiments, the bacteria gradually grew up along the printed alginate structure that had been placed into the culture, incorporating it. After culture, the printed alginate structure was successfully removed revealing porosity where the alginate had been placed. Porosity and interconnectivity of pores in the resultant 3-D architecture can be achieved by porogen introduction using, e.g., ink-jet printer technology.
    • 提出了一种用于控制缠结纤维素纳米纤维网络的3D形状,厚度和结构的新型BC发酵技术。 所得的纳米纤维素基结构可用作生物医学植入物和装置,可用于组织工程和再生医学以及保健产品。 更具体地说,本发明的实施方案涉及使用任何生物制造方法生产和控制由细菌生产的纳米纤维素生物材料的三维结构和形态的系统和方法,包括所公开的新型3-D生物印迹方法。 根据本发明的代表性方法涉及通过细微控制使用微流体系统添加发酵培养基来控制细菌生物材料的生产速率。 在示例性实施方案中,细菌沿已经放入培养物中的印刷的藻酸盐结构逐渐长大,并入其中。 培养后,成功去除了印刷的藻酸盐结构,显示了藻酸盐放置的孔隙度。 所得3-D结构中孔隙的孔隙率和互连性可以通过使用例如喷墨打印机技术的致孔剂引入来实现。